Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac vs Nepafenac Tolerability in Cataract Surgery
NCT02506348Unknown
- Sponsor
- Edith Wolfson Medical Center
- Start
- Jul 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-blind, single-arm trial of diclofenac and nepafenac in cataract, postoperative pain and post-operative inflammation, sponsored by Edith Wolfson Medical Center. Primary endpoint: Patient's comfort at 1 minute post administration. Status: unknown.
02
Drugs
diclofenacnepafenac
03
Conditions
cataractpostoperative painpost-operative inflammation
Beyond the preview
Go deeper on NCT02506348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02506348.